Evan David Seigerman
Stock Analyst at BMO Capital
(3.7)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Outperform | 600 640 | 586.96 | 9.04% | 8 | Aug 4, 2025 | |
REPL Replimune Group | Downgrades: Underperform | 27 2 | 5.53 | -63.83% | 4 | Jul 23, 2025 | |
NGNE Neurogene | Maintains: Outperform | 22 26 | 19.7 | 31.98% | 2 | Jun 12, 2025 | |
MRUS Merus | Maintains: Outperform | 96 110 | 67.28 | 63.5% | 1 | May 23, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Outperform | 24 28 | 26.57 | 5.38% | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 10 | 8.08 | 23.76% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 105 64 | 56.44 | 13.39% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 105 96 | 84.08 | 14.18% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 208 215 | 208.1 | 3.32% | 7 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 362 346 | 287.97 | 20.15% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | 56.99 | 0.02% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 19 | 426.32% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 25.07 | 43.6% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | 58.7 | 22.66% | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 5.91 | -49.24% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 734.18 | -46.06% | 1 | Sep 6, 2022 |